We are pleased to announce that Bushu Pharma has received the 2024 Asia Contract Development and Manufacturing Organization Customer Value Leadership Award from Frost & Sullivan, a leading global research and consulting firm.

In addition to our optimization efforts in our supply chain services with the GATEWAY to ASIA® strategy, which has been highly recognized last 2 year, we were evaluated for our comprehensive services and capabilities to support customers, such as continued facility expansion, obtaining inspection certification from regulatory authorities including the FDA, and promoting the sustainability measures to environment.

Read the full article here: Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs

https://www.frost.com/wp-content/uploads/2024/11/Bushu-Pharma_Award-Writeup.pdf

We will continue to contribute to the medical field by providing new technologies and solutions based on our mission of “Supporting the global healthcare industry to create a healthier tomorrow”.